These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2568416)

  • 1. The antiemetic profile of zacopride.
    Smith WL; Alphin RS; Jackson CB; Sancilio LF
    J Pharm Pharmacol; 1989 Feb; 41(2):101-5. PubMed ID: 2568416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.
    King GL; Landauer MR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1026-33. PubMed ID: 2359014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride.
    Smith WL; Callaham EM; Alphin RS
    J Pharm Pharmacol; 1988 Feb; 40(2):142-3. PubMed ID: 2897451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
    Sancilio LF; Pinkus LM; Jackson CB; Munson HR
    Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the emetic and antiemetic properties of zacopride and its enantiomers.
    Sancilio LF; Pinkus LM; Jackson CB; Munson HR
    Eur J Pharmacol; 1991 Jan; 192(3):365-9. PubMed ID: 2055236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets.
    Yamakuni H; Nakayama H; Matsui S; Imazumi K; Matsuo M; Mutoh S
    J Pharmacol Sci; 2006 May; 101(1):99-102. PubMed ID: 16651699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
    Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
    J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
    Bhandari P; Andrews PL
    Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
    King GL
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
    Fernández AG; Puig J; Beleta J; Doménech T; Bou J; Berga P; Gristwood RW; Roberts DJ
    Eur J Pharmacol; 1992 Nov; 222(2-3):257-64. PubMed ID: 1451737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
    Middlefell VC; Price TL
    Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of the gastric symptoms of radiation sickness.
    Dubois A; Fiala N; Boward CA; Bogo V
    Radiat Res; 1988 Sep; 115(3):595-604. PubMed ID: 3174940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zacopride, a potent 5-HT3 antagonist.
    Smith WW; Sancilio LF; Owera-Atepo JB; Naylor RJ; Lambert L
    J Pharm Pharmacol; 1988 Apr; 40(4):301-2. PubMed ID: 2900319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacopride or GR38032F.
    Mele PC; McDonough JR; McLean DB; O'Halloran KP
    Eur J Pharmacol; 1992 Aug; 218(2-3):229-36. PubMed ID: 1330594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
    Fukuda T; Setoguchi M; Inaba K; Shoji H; Tahara T
    Eur J Pharmacol; 1991 Apr; 196(3):299-305. PubMed ID: 1654255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX.
    Fink-Jensen A; Judge ME; Hansen JB; Jacobsen P; Turski L; Olney J; Honoré T
    Neurosci Lett; 1992 Mar; 137(2):173-7. PubMed ID: 1350077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zatosetron on ipecac-induced emesis in dogs and healthy men.
    Schwartz SM; Goldberg MJ; Gidda JS; Cerimele BJ
    J Clin Pharmacol; 1994 Mar; 34(3):250-4. PubMed ID: 7517409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
    Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.